Background: Study of ERK activation has thus far relied on biochemical assays that are limited to the use of phospho-specific antibodies and radioactivity in vitro, and analysis of whole cell populations in vivo. As with many systems, fluorescence resonance energy transfer (FRET) can be utilized to make highly sensitive detectors of molecular activity. Here we introduce FRET-based ERK Activity Sensors, which utilize variants of Enhanced Green Fluorescent Protein fused by an ERK-specific peptide linker to detect ERK2 activity.
Background
Traditional methods for studying signal transduction cascades have been based solely on biochemical analysis of whole cell populations and homogenized tissues (e.g. radioassays, western blots, etc.). In addition, in vitro studies have required the use of radioactive isotopes for biochemical characterization of kinases. These methods are time consuming, produce large quantities of radioactive waste, and do not allow for the study of real-time kinase dynamics.
Recently, sensors for studying signal molecules in vitro, as well as cascade dynamics in single cells, have been developed utilizing fluorescent proteins and the phenomenon of fluorescence resonance energy transfer (FRET). FRET is a phenomenon by which energy is transferred from one fluorescent molecule to another by way of dipole-dipole interactions during excitation of the donor molecule. FRET efficiency is given by the equation:
where R is the donor-acceptor radius and R o is the radius at which FRET efficiency is 50% (Förster radius). Small changes in R (1-2Å) and small orientation changes between the donor and acceptor fluorophores can dramatically affect the efficiency of FRET, making very small changes in structure easily detectable. The limitation, however, is that FRET is effective only between 10-100Å, and therefore the donor and acceptor must be maintained in close proximity. Genetically encoded fluorescent proteins fused by linker peptide sequences have been utilized to address proximity limitations, as well as facilitate the delivery of the sensor into live cells.
Some of the earliest work done with these sensors includes genetically encoded sensors of caspase activity, in which caspase-3 and caspase-8 sensitive linker peptides were fused between the different variants of Enhanced Green Fluorescent Protein (EGFP) [1] . These studies allowed the characterization of apoptosis in single living cells with spatio-temporal resolution. Other types of FRET signaling sensors have since evolved, including sensors for calcium signaling [2] , receptor tyrosine kinases [3, 4] , intracellular kinases [4] [5] [6] [7] , and histone methylation [8] . These sensors have been shown to be useful in in vitro assays, as well as allow the study of signaling events in a single cell, in real time [4] .
The Ras/ERK cascade controls differentiation and proliferation in many different cell types and organisms. In this signal transduction pathway, activated Ras (Ras-GTP) binds directly to Raf-1 and recruits it to the membrane where Raf becomes activated. Raf then phosphorylates and activates Mek-1 and Mek-2 (the MAPK kinase), which in turn phosphorylate the MAPKs ERK-1 and ERK-2. Activated ERKs translocate to the nucleus and directly phosphorylate transcriptional regulatory proteins (including members of the Ets family of transcription factors, and the bZIP factors Fos and Jun) (reviewed in [9] ). Kinetics and in vivo dynamics of ERK MAP kinase activity are not completely understood. Traditionally, the level of ERK activation has been thought to be relative to the strength of the upstream signal. Some data suggest, however, that ERK activation is "switch-like," requiring a threshold of activation, above which all ERK molecules within the cell become activated [10] . Computational models of MAPK signaling mechanisms can fit both possibilities [11, 12] . Therefore, the development of new tools to study these dynamics is essential to determine the biochemical nature of ERK signaling.
In this manuscript, we describe the development of several FRET-based sensors of MAP kinase activity which we have called ERK Activity Sensors (EAS). Peptide linker sequences taken from the Ets family transcription family members Ets1 and Elk1, both ERK targets, were fused between cyan and yellow variants of EGFP (ECFP and EYFP, respectively). Several of our constructs respond to phosphorylation by activated ERK with changes in FRET, and at least one of them, EAS-3, is specific for active Extracellular Regulated Kinase (ERK) as opposed to two other MAP kinases, p38 and SAPK/JNK. Therefore, EAS-3 is a viable, non-radioactive sensor of ERK MAPK activity in vitro.
Results and discussion
Design and model of EAS EAS was designed to have a short peptide linker sequence sensitive to phosphorylation by ERK fused between ECFP and EYFP. ECFP and EYFP were chosen as a FRET pair because of the good spectral overlap between the emission of ECFP and the excitation of EYFP. We hypothesized that phosphorylation would result in changes in secondary structure of the linker peptide that would alter FRET efficiency for the protein ( Figure 1A ). Since it was unclear which factors would contribute to forming a suitable FRET sensor, we prepared several different constructs with peptide linker sequences containing ERK phosphorylation sites taken from Ets1 and Elk1 transcription factors, which are physiological substrates of the ERK MAPKs (Figure 1B) . EAS-2, derived from mouse Ets1, has a rather large linker peptide, due to the discovery that the MAP Kinase binding site (D-domain) is approximately 90 amino acids downstream of the target serine [13] . The linker sequences for EAS 3-5 were taken from human Elk1, which has been shown to have the DEF domain (FXFP amino-acid motif), a known MAPK binding site, near the C-terminus. These peptides also contain two Serine-Proline (SP) motifs (consensus MAPK phosphorylation sites) corresponding to serines 383 and 389 of Elk1, which have been shown to be targets of MAP kinases. Phosphorylation of these serines has also been shown to be directed specifically by the DEF domain [14] . EAS-Neg is a negative control construct with a short peptide linker derived from Ets1, containing a consensus MAPK phosphorylation site, but no MAPK binding site.
EAS FRET changes in the presence of active ERK2
We expected a change in energy transfer between ECFP and EYFP upon incubation with active ERK2 (pERK2) for EAS to be effective as a real time sensor. This would indicate that a phosphorylation event had affected the distance and orientation between the two fluorophores. Each EAS construct was incubated with pERK2 in a fluorimeter (30°C) and readings were taken prior to addition of ATP. Upon the addition of ATP, all EAS constructs, with the exception of EAS-Neg, showed a decrease of energy transfer indicated by an increase in donor (ECFP) emission (475 nm) with a concomitant decrease in acceptor (EYFP) emission (525 nm) after 40 minutes ( Figure 2A ). Therefore, a decrease in FRET efficiency correlates with phosphorylation of EAS by pERK2. The resultant change in ECFP/EYFP emission ratio is comparable to or exceeds that of similar FRET-based signal transduction sensors [4- A model for EAS activation and construct design 
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upon incubation with pERK2. We refined EAS-3 by replacing the bulky N-terminal GST-purification tag (Glutathione-S-Transferase) with a Histidine-10 tag on the C-terminus. This reduced the possibility that the large purification tag would interfere with FRET efficiency changes. In addition, we mutated alanine 207 and alanine 487 to lysine. As previously reported, this prevents EGFP dimerization [15] . This latter modification reduced copurification of truncation products with full-length EAS (data not shown).
To further characterize EAS-3, we generated different constructs targeting critical residues, and analyzed their ability to serve as substrates for pERK2. Mutants EAS3-S286A, EAS3-S292A, and the double mutant EAS3-S(286,292)A eliminated consensus phosphorylation sites (Figure 2A ). The dead binding domain mutant (EAS3-DBD) eliminated the DEF domain by replacing the two key phenylalanines with alanines, creating an AXAP motif ( Figure 3A ). As Figure 3B demonstrates, all five mutants have decreased phosphorylation compared to the wild type sensor. As expected, the EAS3-S(286,292)A mutant had the lowest level of phosphate incorporation due to absence of both serine-proline consensus phosphorylation sites required by MAP Kinases. A decrease in phosphorylation of EAS-DBD iss also consistent with the requirement of MAPKs to bind targets for efficient phosphorylation (reviewed in [16] ). Differences between wildtype EAS-3 and mutants are also reflected in change of FRET efficiency when treated with pERK2 in fluorimeter experiments ( Figure 3C ). These relative changes in FRET efficiency are consistent with the radioassay data.
EAS-3 is not phosphorylated by pSAPK or pp38
Distinguishing the activation of different MAP kinases within the cell is essential since each MAPK pathway is activated by multiple mitogens and external environmental factors to varying degrees (reviewed in [17] ). Furthermore, there is extensive cross-talk between the different MAP kinase pathways. Detection methods must effectively isolate the signal of the target kinase from other family members to elucidate the contributions of these different pathways to a given cellular process.
The target peptide linkers were designed to impart specificity for ERK. Elk1 and Ets1 were chosen because of their seemingly specific interaction with ERK relative to p38 or SAPK/JNK (reviewed in [18] ). To determine whether EAS-3 acted as a specific substrate for ERK we performed in vitro phosphorylation assays to quantify the ability of pERK2, pp38, and pSAPK/JNK to phosphorylate EAS-3 ( Figure 4 ). As shown in Figure 4A , EAS-3 is an approximately 2000-fold more specific target for pERK2 than pp38, and 50-fold more specific for pERK2 than pSAPK/ JNK. Activities of pERK2, pp38 and pSAPK/JNK were Mutation of key residues diminishes EAS-3 phosphorylation by pERK2 confirmed by using known substrates specific for each kinase ( Figure 4B ). MBP was used in conjuction with pERK2, GST-ATF2 with pp38, and GST-c-Jun with pSAPK/ JNK. Specificity of these kinases for EAS-3 was also confirmed by FRET in a fluorimeter ( Figure 4C ). It is clear that the change in FRET was dramatic when EAS-3 was incubated with pERK2, but showed little or no response when incubated with pp38 or pSAPK/JNK. This is consistent with the results found in 4A. Given the similarity of these kinases, this also suggests that EAS-3 would be specifically acted upon by pERK2 even in the presence of other activated intracellular kinases.
The demonstrated specificity of pERK2 for EAS-3 phosphorylation suggests that this sensor is a candidate for in vivo studies of ERK signaling. However, our preliminary experiments in NIH-3T3 cells indicated that EAS-3 was susceptible to intracellular phosphatase activity (data not shown). We surmise that this is due to the absence of a protective phospho-specific binding domain within the EAS-3 construct. Such binding domains have been crucial in the development of other FRET-based signaling sensors of kinase activity [2] [3] [4] 6, 7] . These binding domains, however, are taken from naturally occurring domains that are specific for each target sequence. Unfortunately, no known phospho-specific binding domain exists for Elk1
Determination of ERK2 specificity for EAS-3 in the region of Ser383/389. Therefore, we are using a semi-rational approach to develop a phospho-specific binding domain that acts to protect the phosphorylated EAS-3 linker from intracellular phosphatases. This will enable us to adapt the EAS-3 sensor for use in live cells.
Conclusion
These results show that our novel ERK Activity Sensors provide real-time in vitro detection of MAP kinase activity. This method can be applied to studying kinetics of ERK activity in real time, as well as detection of ERK activity in unknown cell lysate fractions. There is also the potential to use these sensors for high-throughput screening of ERK kinase activity with fluorescence plate readers. This method is more direct and convenient to monitor ERK activation in vitro than conventional assays that either use radioactivity for detection or rely on indirect detection using phospho-specific antibodies for MAPK targets.
Methods

EAS constructs
DNA coding for peptide linkers was amplified by PCR with primers designed with Bgl II and BamHI sites at the 5' and 3' ends, respectively. The products were cloned into pECFP-C1 (Clontech), and EYFP from pEYFP-N1 was subsequently cloned in frame to create EAS constructs. EAS's were cloned into pGEX-2T (Amersham) in frame with GST for expression and purification purposes. These GSTtagged constructs were used for initial fluorimetry experiment of EAS constructs. Other versions of EAS's were constructed using ECFP and EYFP with mutation A(207,487)K, which eliminates dimerization of GFPs, and cloned into pET21a (Novagen) with a Histidine-10 tag. These His10-tagged constructs were used for mutant and specificity experiments. EAS-3 linker mutants were made by Quickchange Site Directed Mutagenesis (Stratagene) to make either single or double point mutation within the peptide linker. For expression in NIH-3T3 cells, EAS's were cloned into the pECFP vector backbone without tags.
EAS and active kinase expression BL21(DE3) cells were transformed with EAS constructs and plated on LB agar supplemented with 100 µg/ml ampicillin. Colonies were picked into 4 ml LB-Amp and shaken overnight at 30°C. 250 ml LB was inoculated with starter culture, grown to A 600 of 0.6, and induced with 0.1 mM IPTG for 18 hours. Cells were spun down, lysed by french press, and cell fragments were spun down at 18,000 rpm in a Beckman JA-20 rotor for 30 min. Proteins were purified from lysates over Ni-NTA Superflow (Qiagen) or Glutathione Sepharose 4B (Amersham).
